KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Equity IncomeIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Inovio Pharmaceuticals (INO) Net Income - Minority (2020)

Historic Net Income - Minority for Inovio Pharmaceuticals (INO) over the last 4 years, with Q3 2020 value amounting to -$96269.0.

  • Inovio Pharmaceuticals' Net Income - Minority changed N/A to -$96269.0 in Q3 2020 from the same period last year, while for Sep 2020 it was -$96269.0, marking a year-over-year change of. This contributed to the annual value of -$597918.0 for FY2010, which is 400.57% up from last year.
  • As of Q3 2020, Inovio Pharmaceuticals' Net Income - Minority stood at -$96269.0.
  • In the past 5 years, Inovio Pharmaceuticals' Net Income - Minority registered a high of -$96269.0 during Q2 2020, and its lowest value of -$96269.0 during Q2 2020.